Singapore markets close in 11 minutes

Atea Pharmaceuticals, Inc. (AVIR)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
4.8000+0.0200 (+0.42%)
At close: 04:00PM EST
4.8000 0.00 (0.00%)
After hours: 04:02PM EST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
31/12/2018
Total revenue
192,180
351,367
48,633
0
0
Operating expenses
Research development
112,207
167,205
38,023
10,170
6,675
Selling general and administrative
49,543
45,785
21,640
4,438
2,802
Total operating expenses
161,750
212,990
59,663
14,608
9,477
Operating income or loss
30,430
138,377
-11,030
-14,608
-9,477
Income before tax
36,041
138,590
-10,947
-14,034
-9,064
Income tax expense
387
17,400
-
-
-
Income from continuing operations
35,654
121,190
-10,947
-14,034
-9,064
Net income
35,654
121,190
-10,947
-14,034
-9,064
Net income available to common shareholders
35,654
121,190
-10,947
-14,034
-9,064
Basic EPS
-
1.46
-0.51
-0.32
-0.19
Diluted EPS
-
1.37
-0.51
-0.32
-0.19
Basic average shares
-
82,820
21,592
43,737
47,293
Diluted average shares
-
88,249
21,592
43,737
47,293
EBITDA
-
138,406
-11,011
-14,591
-9,460